PMC:7299399 / 30127-30290 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T128","span":{"begin":69,"end":71},"obj":"Body_part"},{"id":"T129","span":{"begin":96,"end":98},"obj":"Body_part"},{"id":"T130","span":{"begin":110,"end":118},"obj":"Body_part"},{"id":"T131","span":{"begin":138,"end":140},"obj":"Body_part"}],"attributes":[{"id":"A128","pred":"fma_id","subj":"T128","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A129","pred":"fma_id","subj":"T129","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A130","pred":"fma_id","subj":"T130","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A131","pred":"fma_id","subj":"T131","obj":"http://purl.org/sig/ont/fma/fma86578"}],"text":"Ongoing clinical trials are testing drugs that block the receptor of IL-6 (Tocilizumab, an anti-IL-6 receptor antibody, and Sarilumab) or IL-6 itself (Siltuximab)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T280","span":{"begin":28,"end":35},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"Ongoing clinical trials are testing drugs that block the receptor of IL-6 (Tocilizumab, an anti-IL-6 receptor antibody, and Sarilumab) or IL-6 itself (Siltuximab)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T221","span":{"begin":36,"end":41},"obj":"Chemical"},{"id":"T222","span":{"begin":69,"end":71},"obj":"Chemical"},{"id":"T224","span":{"begin":96,"end":98},"obj":"Chemical"},{"id":"T226","span":{"begin":138,"end":140},"obj":"Chemical"}],"attributes":[{"id":"A221","pred":"chebi_id","subj":"T221","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A222","pred":"chebi_id","subj":"T222","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A223","pred":"chebi_id","subj":"T222","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A224","pred":"chebi_id","subj":"T224","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A225","pred":"chebi_id","subj":"T224","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A226","pred":"chebi_id","subj":"T226","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A227","pred":"chebi_id","subj":"T226","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"}],"text":"Ongoing clinical trials are testing drugs that block the receptor of IL-6 (Tocilizumab, an anti-IL-6 receptor antibody, and Sarilumab) or IL-6 itself (Siltuximab)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T117","span":{"begin":0,"end":163},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Ongoing clinical trials are testing drugs that block the receptor of IL-6 (Tocilizumab, an anti-IL-6 receptor antibody, and Sarilumab) or IL-6 itself (Siltuximab)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"465","span":{"begin":69,"end":73},"obj":"Gene"},{"id":"466","span":{"begin":96,"end":100},"obj":"Gene"},{"id":"467","span":{"begin":138,"end":142},"obj":"Gene"},{"id":"471","span":{"begin":75,"end":86},"obj":"Chemical"},{"id":"472","span":{"begin":124,"end":133},"obj":"Chemical"},{"id":"473","span":{"begin":151,"end":161},"obj":"Chemical"}],"attributes":[{"id":"A465","pred":"tao:has_database_id","subj":"465","obj":"Gene:3569"},{"id":"A466","pred":"tao:has_database_id","subj":"466","obj":"Gene:3569"},{"id":"A467","pred":"tao:has_database_id","subj":"467","obj":"Gene:3569"},{"id":"A471","pred":"tao:has_database_id","subj":"471","obj":"MESH:C502936"},{"id":"A472","pred":"tao:has_database_id","subj":"472","obj":"MESH:C000592401"},{"id":"A473","pred":"tao:has_database_id","subj":"473","obj":"MESH:C504234"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Ongoing clinical trials are testing drugs that block the receptor of IL-6 (Tocilizumab, an anti-IL-6 receptor antibody, and Sarilumab) or IL-6 itself (Siltuximab)."}